Peroxiredoxin 5 Expression in the Human Thyroid Gland
Authors:
- 1 March 2005
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 15 (3) , 205-209
Abstract
Peroxiredoxin 5 (PRDX5) is a newly discovered thioredoxin peroxidase able to reduce peroxides that is implicated in antioxidant protective mechanisms. We report here its expression in the human thyroid gland. Twentyseven human thyroid specimens were examined by immunohistochemistry. They included six normal thyroid tissues, five multinodular goiters, nine hot nodules, two Hürthle cell adenomas, and five thyroids from patients with Graves' disease. In the control tissue, PRDX5 expression was heterogeneous, being stronger in cubical functionally active follicular cells than in flat quiescent thyrocytes. It was diffuse in the cytoplasm, occasionally localized in inclusions that most likely corresponded to mitochondria. This feature was particularly marked in the Hürthle cell adenoma case. In multinodular goiters, hot nodules, and Graves' thyroids, the cytosolic labeling was enhanced compared to the control tissue and a signal was also detected in few nuclei. To determine whether the level of expression was different between multinodular goiters and hyperthyroid Graves' thyroids, PRDX5 immunoblotting was performed in these two respective tissues. We observed that PRDX5 expression was higher in the thyroid gland of patients with Graves' disease compared to multinodular goiters. In conclusion, our data show that PRDX5 is expressed in the thyroid gland where it could act as antioxidant. The level of expression is directly correlated with the functional status of epithelial cells, being higher in multinodular goiters, and even more pronounced in hyperthyroid tissues, such as Graves' disease.Keywords
This publication has 18 references indexed in Scilit:
- Evidence for processing of compact insoluble thyroglobulin globules in relation with follicular cell functional activity in the human and the mouse thyroidEuropean Journal of Endocrinology, 2004
- Correlation between the Loss of Thyroglobulin Iodination and the Expression of Thyroid-Specific Proteins Involved in Iodine Metabolism in Thyroid CarcinomasThe Journal of Clinical Endocrinology & Metabolism, 2003
- Proteomics Analysis of Cellular Response to Oxidative StressJournal of Biological Chemistry, 2002
- Nitric oxide is involved in interleukin-1alpha-induced cytotoxicity in polarised human thyrocytesJournal of Endocrinology, 2002
- Structural Changes in the Angiofollicular Units between Active and Hypofunctioning Follicles Align with Differences in the Epithelial Expression of Newly Discovered Proteins Involved in Iodine Transport and OrganificationThe Journal of Clinical Endocrinology & Metabolism, 2002
- PeroxiredoxinsBiological Chemistry, 2002
- Crystal structure of human peroxiredoxin 5, a novel type of mammalian peroxiredoxin at 1.5 Å resolutionJournal of Molecular Biology, 2001
- Cloning of Two Human Thyroid cDNAs Encoding New Members of the NADPH Oxidase FamilyJournal of Biological Chemistry, 2000
- Role of Peroxiredoxins in Regulating Intracellular Hydrogen Peroxide and Hydrogen Peroxide-induced Apoptosis in Thyroid CellsJournal of Biological Chemistry, 2000
- Two-step development of Hashimoto-like thyroiditis in genetically autoimmune prone non-obese diabetic mice: effects of iodine-induced cell necrosisJournal of Endocrinology, 1995